ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
Cardiology This Week: A concise summary of recent studies
Magnetic Resonance Imaging, pacemakers and ICDs
Tough problems in the treatment of hypertension
Snapshots
Host: Rick Grobbee
Guests: Stephan Achenbach, Chiara Bucciarelli-Ducci, Christophe Leclerq, Bryan Williams.
Want to watch that episode? Go to: https://esc365.escardio.org/event/1123
Disclaimer
This programme is supported by Siemens Healthineers in the form of an educational grant. The scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Chiara Bucciarelli-Ducci has declared to have potential conflicts of interest to report: CEO (part time) of the Society for Cardiovascular Magnetic Resonance.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Christophe Leclerq has declared to have potential conflicts of interest to report: lectures and consultancies for Abbott, Biotronik, and Medtronic.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
Bryan Williams has declared to have potential conflicts of interest to report: chair of steering committees for trails for Novartis and AstraZeneca.
